Skip to content
New research conducted by The Anschutz Medical Campus at the University of Colorado discovers that two FDA-approved drugs can help improve cognition in Alzheimer’s […]
Two FDA-approved drugs can improve cognition in Alzheimer’s patients Read More »
A new zoonotic virus – meaning a virus derived from animals – has jumped to humans and put health authorities on high alert, after
Dangerous new zoonotic virus spreads, causing health scare Read More »
August is National Immunization Awareness Month—a time to spotlight the critical role of vaccines in preventing infectious disease and addressing new pandemic threats. During
National Immunization Awareness Month highlights how vaccines save lives Read More »
The majority of the rebates received from drug manufacturers are kept by pharmacy benefit managers (PBMs), which do not use the funds to reduce
PBMs’ rebates don’t reach patients, analysis finds Read More »
The PD-1 inhibitor tislelizumab “met the primary endpoint of non-inferior overall survival (OS) versus sorafenib” in the global Phase 3 trial as a first-line
Every year, bad weather events around the globe are exacerbated and new records are broken, a Nature study about climate change states. Extreme heat
Climate change exacerbates infectious disease, finds new study Read More »
The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for a monkeypox vaccine that allow five-fold the number of
Monkeypox vaccine EUA will increase available doses Read More »
A new bacteria has made a home in the Gulf Coast region and scientists are not happy. Burkholderia pseudomallei is typically endemic to much
Deadly bacteria found for the first time on the Gulf Coast – and it won’t be the last Read More »
Pharmaceutical and biotech giant Pfizer joined by specialty vaccine company Valneva announced on Tuesday that they’ve started Phase 3 clinical study for Vaccine Against
Pfizer-Valneva’s Lyme disease vaccine enters phase 3 amid rising incidence Read More »
In a $5.4 billion deal that will boost its rare disease treatment business, Pfizer is buying the pioneer in treatments for sickle cell disease,
Global Blood Therapeutics acquisition to boost Pfizer’s sickle cell pipeline Read More »
